Skip to main content

Advertisement

Figure 3 | Clinical Proteomics

Figure 3

From: Identification of a seven glycopeptide signature for malignant pleural mesothelioma in human serum by selected reaction monitoring

Figure 3

Concentration ranges of proteins originating MPM candidate biomarker peptides detected through SRM-assays in serum. Reported are protein concentrations in serum/plasma available from the PeptideAtlas database [32] (red dots) (Additional file 7: Table S4). For comparison, cut-off levels of selected MPM biomarkers in serum/plasma proposed by the literature [11, 3336] are reported (blue dots). Concentrations are reported in logarithmic scale.

Back to article page